AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2024
Nov 5, 2024
29745_dirs_2024-11-05_582c533e-b6c9-4849-894c-d101bd399491.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2024-11-01
Reporting Person: Hernandez Edgardo (EVP & Pres., Mfg. Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-11-01 | Common Stock | M | 1687 | — | Acquired | 31369 | Direct |
| 2024-11-01 | Common Stock | F | 750.799 | $818.93 | Disposed | 30618.201 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-11-01 | Restricted Stock Unit | $ | M | 1687 | Disposed | 2024-11-01 | Common Stock (1687) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 865.22 | Indirect |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
More from ELI LILLY & Co
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29